Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Inhalation Sciences receives service orders from recurring global pharma customers

The clients, who have been customers of ISAB for many years, continue to use ISAB’s inhalation research instruments on a regular basis and have consistently expressed strong satisfaction with the performance and reliability of ISAB’s technology.

Manoush Masarrat, CEO of Inhalation Sciences, comments:

“We are very pleased to once again be entrusted with orders from longstanding global clients. Their continued use of our systems underscores the quality and scientific value our instruments provide to leading pharmaceutical research. We look forward to supporting their projects and contributing to their long-term success in inhalation development.”

For more information, please contact:
Manoush Masarrat, CEO
Phone: +46 (0) 73 628 9153
E-mail: manoush.masarrat@inhalation.se

About Inhalation Sciences Sweden AB (publ)
Inhalation Sciences is a cutting-edge Contract Research Organization (CRO) specializing in inhalation drug development. Leveraging our proprietary technology platform, PreciseInhale®, we empower our clients to de-risk and accelerate their R&D pipelines by delivering high-resolution, predictive data early in the development process.